Literature DB >> 15213077

Dose comparison of tranexamic acid in pediatric cardiac surgery.

Sandeep Chauhan1, Akshay Bisoi, Neeraj Kumar, Dinesh Mittal, Shailaja Kale, Usha Kiran, Panangipalli Venugopal.   

Abstract

To compare different doses of tranexamic acid, 150 consecutive children with congenital cyanotic heart disease were randomly assigned to one of 5 groups of 30 each. Group A served as a control. Group B received 50 mg.kg(-1) of tranexamic acid at induction of anesthesia. Group C received 10 mg.kg(-1) at induction followed by an infusion of 1 mg.kg(-1).h(-1). Group D had 10 mg.kg(-1) at induction, 10 mg.kg(-1) on bypass, and 10 mg.kg(-1) after protamine. Group E had 20 mg.kg(-1) at induction and again after protamine. The control group had the longest sternal closure time, the greatest blood loss in the first 24 hours, and the highest requirements for blood and blood products. Among the 4 groups given tranexamic acid, group D (triple dose) had the best results, followed by group E (double dose). Group B (single dose) had the worst results among the groups receiving tranexamic acid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213077     DOI: 10.1177/021849230401200208

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  10 in total

Review 1.  The pediatric cardiology pharmacopeia: 2013 update.

Authors:  Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra-id Abdulla
Journal:  Pediatr Cardiol       Date:  2012-11-29       Impact factor: 1.655

2.  Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.

Authors:  Kazuyoshi Shimizu; Yuichiro Toda; Tatsuo Iwasaki; Mamoru Takeuchi; Hiroshi Morimatsu; Moritoki Egi; Tomohiko Suemori; Satoshi Suzuki; Kiyoshi Morita; Shunji Sano
Journal:  J Anesth       Date:  2011-09-24       Impact factor: 2.078

3.  Temporally and regionally disparate differences in plasmin activity by tranexamic acid.

Authors:  Daryl L Reust; Scott T Reeves; James H Abernathy; Jennifer A Dixon; William F Gaillard; Rupak Mukherjee; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Anesth Analg       Date:  2010-03-01       Impact factor: 5.108

Review 4.  Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2012-03-26       Impact factor: 11.431

Review 5.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Authors:  Katharine Ker; Phil Edwards; Pablo Perel; Haleema Shakur; Ian Roberts
Journal:  BMJ       Date:  2012-05-17

6.  Effects of tranexamic acid during endoscopic sinsus surgery in children.

Authors:  Ahmed A Eldaba; Yasser Mohamed Amr; Osama A Albirmawy
Journal:  Saudi J Anaesth       Date:  2013-07

7.  Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children.

Authors:  Nagarajan Muthialu; Soundaravalli Balakrishnan; Rajani Sundar; Srinivasan Muralidharan
Journal:  Ann Card Anaesth       Date:  2015 Jan-Mar

8.  Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.

Authors:  Sandeep Chauhan
Journal:  Ann Card Anaesth       Date:  2015 Jan-Mar

9.  Tranexamic acid reduces blood loss in paediatric proximal femoral and/or pelvic osteotomies.

Authors:  Anne J Brouwer; Dagmar R J Kempink; Pieter Bas de Witte
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

Review 10.  Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.

Authors:  Ingrid Pabinger; Dietmar Fries; Herbert Schöchl; Werner Streif; Wolfgang Toller
Journal:  Wien Klin Wochenschr       Date:  2017-04-21       Impact factor: 1.704

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.